These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. Angel JB; Routy JP; Tremblay C; Ayers D; Woods R; Singer J; Bernard N; Kovacs C; Smaill F; Gurunathan S; Sekaly RP AIDS; 2011 Mar; 25(6):731-9. PubMed ID: 21330911 [TBL] [Abstract][Full Text] [Related]
3. A primer on HIV type 1-specific immune function and REMUNE. Moss RB; Giermakowska WK; Savary JR; Theofan G; Daigle AE; Richieri SP; Jensen FC; Carlo DJ AIDS Res Hum Retroviruses; 1998 Jun; 14 Suppl 2():S167-75. PubMed ID: 9672235 [TBL] [Abstract][Full Text] [Related]
4. A boost for the immune system. TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925 [TBL] [Abstract][Full Text] [Related]
5. Remune trial will stop; new trials planned. James JS AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461 [TBL] [Abstract][Full Text] [Related]
6. Remune bites the dust...again. Vázquez E Posit Aware; 2001; 12(5):21. PubMed ID: 11688479 [No Abstract] [Full Text] [Related]
11. Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan Dawson. Moss R STEP Perspect; 1998; 98(2):13-6. PubMed ID: 11365540 [TBL] [Abstract][Full Text] [Related]
12. Remune trials recruiting. PI Perspect; 1996 Sep; (No 19):17. PubMed ID: 11363901 [TBL] [Abstract][Full Text] [Related]